SCHEMBL931611

SCHEMBL931611

CC1=NC(c2ccc(O)c(-c3cnccn3)c2)(C2CC2)N=C1N

nearest known ligand 0.68

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 13/20 0.68
KCNH2 Q12809 6/20 0.60
BACE2 Q9Y5Z0 2/20 0.46
HDAC3 O15379 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC2 Q92769 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL932236 0.85 BACE1 (0.53) BACE1KCNH2BACE2
SCHEMBL931716 0.68 BACE1 (0.78) BACE1KCNH2BACE2
SCHEMBL932165 0.65 BACE1 (0.79) BACE1KCNH2BACE2
SCHEMBL931601 0.65 BACE1 (0.50) BACE1KCNH2BACE2
SCHEMBL6892665 0.65 BACE1 (0.80) BACE1KCNH2BACE2
SCHEMBL22026014 0.61 BACE1 (0.55) BACE1BACE2
SCHEMBL932399 0.60 BACE1 (0.53) BACE1KCNH2BACE2
SCHEMBL31681935 0.58 IDO1 (0.47)
SCHEMBL11886380 0.58 IDO1 (0.47)
SCHEMBL9685101 0.57 RAB9A (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO claimed
WO-2011002408-A1 NOVEL COMPOUNDS FOR TREATMENT OF NEURODEGENERATION ASSOCIATED WITH DISEASES, SUCH AS ALZHEIMER'S DISEASE OR DEMENTIA ASTRAZENECA AB (SE) 2011-01-06 WO disclosed